Nalaganje...
Small Molecule Inhibitors of the PCSK9·LDLR Interaction
The protein–protein interaction between proprotein convertase subtilisin/kexin type 9 (PCSK9) and low-density lipoprotein receptor (LDLR) is a relatively new, and extremely important, validated therapeutic target for treatment and prevention of heart disease. Experts in the area agree that the first...
Shranjeno v:
| izdano v: | J Am Chem Soc |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404525/ https://ncbi.nlm.nih.gov/pubmed/29378408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jacs.7b09360 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|